« SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and | Main | FDA Advances Federal E-Health Effort FDA is moving the effort »

FDA Approvals - BioBalance Corporation to Present at Rodman & Renshaw Healthcare Conference


BioBalance Corporation to Present at Rodman & Renshaw Healthcare Conference in Monte Carlo (Market Wire via Yahoo! Finance)
BioBalance Corporation, a wholly owned subsidiary of New York Health Care, Inc. (OTC BB: BBAL), will present at the Rodman & Renshaw 3rd Annual Healthcare Conference being held on May 15-16, 2006 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.

Glenmark USA acquires exclusive marketing rights to 3 generics from Aspen (PharmaBiz)
Glenmark Pharmaceuticals Inc., USA [GPI], the wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. signed a supply and marketing agreement with Aspen USA, Inc. for the joint manufacturing and marketing of three generic controlled-substance pharmaceutical products for the US market.
 

©2006 FDA-News.com. All rights reserved.